A citation-based method for searching scientific literature

Ele Ferrannini, Simona Baldi, Silvia Frascerra, Brenno Astiarraga, Tim Heise, Roberto Bizzotto, Andrea Mari, Thomas R Pieber, Elza Muscelli. Diabetes 2016
Times Cited: 259



Subodh Verma, Sonia Rawat, Kim L Ho, Cory S Wagg, Liyan Zhang, Hwee Teoh, John E Dyck, Golam M Uddin, Gavin Y Oudit, Eric Mayoux, Michael Lehrke, Nikolaus Marx, Gary D Lopaschuk. JACC Basic Transl Sci 2018
Times Cited: 125




List of shared articles



Times cited


SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism.
Xiaodan Wang, Jingyu Ni, Rui Guo, Lan Li, Jing Su, Feng He, Guanwei Fan. Heart Fail Rev 2021
0

Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics.
Zhenghong Liu, Xiaoxuan Ma, Iqra Ilyas, Xueying Zheng, Sihui Luo, Peter J Little, Danielle Kamato, Amirhossein Sahebkar, Weiming Wu, Jianping Weng,[...]. Theranostics 2021
6

Could Dapagliflozin Attenuate COVID-19 Progression in High-Risk Patients With or Without Diabetes? Behind DARE-19 Concept.
Georgia Anastasiou, Erifili Hatziagelaki, Evangelos Liberopoulos. J Cardiovasc Pharmacol 2021
2

Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms.
Lei Xiao, Xin Nie, Yanyan Cheng, Nanping Wang. Cardiovasc Drugs Ther 2021
0

Ketone body metabolism in diabetic and non-diabetic heart failure.
Ningjing Qian, Yaping Wang. Heart Fail Rev 2020
3

Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure.
Nikole J Byrne, Nobutoshi Matsumura, Zaid H Maayah, Mourad Ferdaoussi, Shingo Takahara, Ahmed M Darwesh, Jody L Levasseur, James Won Suk Jahng, Dyonne Vos, Nirmal Parajuli,[...]. Circ Heart Fail 2020
35


CaMKII and GLUT1 in heart failure and the role of gliflozins.
M Trum, S Wagner, L S Maier, J Mustroph. Biochim Biophys Acta Mol Basis Dis 2020
6

Cardiac ketone body metabolism.
Azrul Abdul Kadir, Kieran Clarke, Rhys D Evans. Biochim Biophys Acta Mol Basis Dis 2020
13

Empagliflozin improves left ventricular diastolic function of db/db mice.
Julia Moellmann, Barbara M Klinkhammer, Patrick Droste, Ben Kappel, Elias Haj-Yehia, Sebastian Maxeiner, Anna Artati, Jerzy Adamski, Peter Boor, Katharina Schütt,[...]. Biochim Biophys Acta Mol Basis Dis 2020
11

Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
Senthil Selvaraj, Daniel P Kelly, Kenneth B Margulies. Circulation 2020
17


Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology.
Petar M Seferović, Gabriele Fragasso, Mark Petrie, Wilfried Mullens, Roberto Ferrari, Thomas Thum, Johann Bauersachs, Stefan D Anker, Robin Ray, Yuksel Çavuşoğlu,[...]. Eur J Heart Fail 2020
26

Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes.
Oliver Schnell, Paul Valensi, Eberhard Standl, Antonio Ceriello. Endocrinol Diabetes Metab 2020
1